New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...
Jacob Steven Leach, DexCom, Inc.'s President and CEO who will summarize our recent highlights and ongoing strategic initiatives. Please note that there are also slides available related to our fourth ...
Abstract: This article introduces a novel clustering and routing protocol for Internet of Things (IoT) sensor networks aimed at reducing energy consumption and extending the lifespan, a critical ...